Comparative real-world study of apalutamide and darolutamide in Japanese patients with non-metastatic castration-resistant prostate cancer
DARO was associated with a lower incidence of TRAEs compared to APA. Rash was more prevalent with APA. Elevated baseline PSA and suboptimal PSA response were associated with progression.
Authors
- Jun-ichi Teranishi
- Takashi Kawahara (ORCID: https://orcid.org/0000-0002-7049-3379)
- Yusuke Ito (ORCID: https://orcid.org/0000-0002-3239-1152)
- Koichi Uemura (ORCID: https://orcid.org/0009-0001-5761-3508)
- Hiroki Ito (ORCID: https://orcid.org/0000-0002-4433-370X)
- Hisashi Hasumi (ORCID: https://orcid.org/0000-0001-8211-8835)
- Kazuhide Makiyama (ORCID: https://orcid.org/0000-0002-7449-2015)
- Maiko Ikeda
- Hiroji Uemura (ORCID: https://orcid.org/0000-0003-3775-2671)
Institutions
- Yokohama City University Medical Center (JP)
- Shonan Kamakura General Hospital (JP)
- Yokohama City University (JP)
Publication Details
- Journal
- BMC Urology
- Published
- 2025-09-26
- DOI
- https://doi.org/10.1186/s12894-025-01919-z
- Citations
- 1
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 1.52